- Impact of vitamin D and Zinc sufficiency on immune responses following COVID-19 vaccinations among healthcare workers
- VitaminDWiki - COVID and Zinc - many studies
- 5,540 studies with COVID, ZINC, VITAMIN D AND (BOOSTER OR VACCINATION)
- 675 studies with COVID, ZINC, VITAMIN D, ADVERSE AND (BOOSTER OR VACCINATION)
Impact of vitamin D and Zinc sufficiency on immune responses following COVID-19 vaccinations among healthcare workers
Clin Exp Vaccine Res. 2025;14:e17 https://doi.org/10.7774/cevr.2025.14.e17
Collins Amadi,1,2 Stephenson D. Lawson,3,4 Johnbosco Chidozie Okafor,5 and Ezra Agbo6
Introduction
Vitamin D and zinc sufficiency are theoretically acclaimed to influence immune-boosting potentials following various immunizations. Herein, we explored the impact of these micronutrients on immune responses following Oxford-AstraZeneca coronavirus disease 2019 (COVID-19) vaccination among Nigerians.
Methods
Two hundred healthcare workers (HCs) who presented at the Rivers State University Teaching Hospital were recruited during the first dose and followed up 4 weeks post-first and post-second doses. Data (serum vitamin D/zinc, COVID-19 anti-spike immunoglobulin G [ASIgG]) were determined on the day of the first dose and repeated 4 weeks post-first dose and 4 weeks post-second dose. Vitamin D (VitD) status, assessed using serum 25(OH)D, was categorized as sufficient (≥50 nmol/L) or insufficient/deficient (<50 nmol/L) while zinc status was categorized as sufficient (≥11.3 µmol/L) or insufficient (<11.3 µmol/L). Post-second dose ASIgG titer status was categorized as optimal (>7,352 AU/mL) or sub-optimal (<7,352 AU/mL) as defined by the World Health Organization. Statistical significance was defined as p<0.05.
Results
HCs with both VitD and zinc sufficiency (n=97) had higher ASIgG titer levels (4 weeks post-first dose=15,977±367.88 AU/mL; 4 weeks post-second dose=22,603±451.18 AU/mL) after the first and second doses compared to only the VitD sufficient (n=58) cohorts (4 weeks post-first dose=4,680±154.77 AU/mL; 4 weeks post-second dose=7,850±200.60 AU/mL) and the zinc-sufficient (n=63) cohorts (4 weeks post-first dose=5,770±160.41 AU/mL; 4 weeks post-second dose=8,100±206.91 AU/mL) (p<0.05).
The VitD and zinc-sufficient HCs were also more likely to achieve optimal ASIgG titer levels (odds ratio, 2.97; 95% confidence interval, 2.11–4.123; p<0.001) 4 weeks post-second dose following adjustment for confounders.
Conclusion
VitD and zinc sufficiency had a positive impact on immune responses following AstraZeneca COVID-19 vaccination.
Download the PDF from VitaminDWiki
VitaminDWiki - COVID and Zinc - many studies
- COVID was associated with low Vitamin D or Zinc – umbrella review Feb 2023
- COVID-19 risk reduced 4X by each of: Vitamin D, Omega-3, Curcumin, Zinc (each increases D in cells)
- Zinc (which increases vitamin D in tissues) may both prevent and treat COVID-19
- 7 reasons to think that Zinc should fight COVID-19 – July 2020
5,540 studies with COVID, ZINC, VITAMIN D AND (BOOSTER OR VACCINATION)
675 studies with COVID, ZINC, VITAMIN D, ADVERSE AND (BOOSTER OR VACCINATION)
- Micronutrient supplementation before COVID-19 vaccination can protect against adverse effects - Nov 2021 doi: 10.1016/j.clnesp.2021.11.008
- vitamin D, selenium and zinc